These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 12616848)

  • 1. Patient information leaflets--helpful guidance or a source of confusion?
    Bjerrum L; Foged A
    Pharmacoepidemiol Drug Saf; 2003; 12(1):55-9. PubMed ID: 12616848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan.
    Rohra DK; Gilani AH; Memon IK; Perven G; Khan MT; Zafar H; Kumar R
    J Pharm Pharm Sci; 2006; 9(1):50-9. PubMed ID: 16849008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How (not) to inform patients about drug use: use and effects of negations in Dutch patient information leaflets.
    Burgers C; Beukeboom CJ; Sparks L; Diepeveen V
    Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):137-43. PubMed ID: 25044310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Patient education responsibility, specialty and administration information from the internal medicine viewpoint].
    Ludwig WD
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):657-61. PubMed ID: 9527464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives.
    Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supreme Court decision may have major impact on drug industry.
    Spurgeon D
    CMAJ; 1993 Feb; 148(4):629-31. PubMed ID: 8431828
    [No Abstract]   [Full Text] [Related]  

  • 7. Patient information leaflets for antidepressants: are patients getting the information they need?
    Haw C; Stubbs J
    J Affect Disord; 2011 Jan; 128(1-2):165-70. PubMed ID: 20656359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA's Rx for better medication information.
    Farley D
    FDA Consum; 1995 Nov; 29(9):5-10. PubMed ID: 10152787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised comparison of the effect of three patient information leaflet models on older patients' treatment intentions.
    Whatley S; Mamdani M; Upshur RE
    Br J Gen Pract; 2002 Jun; 52(479):483-4. PubMed ID: 12051214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Information on marketed drugs for doctors and patients. Experience in six European countries.
    Brown P; Charlish P; Brazier H; Butterfield M
    Int J Technol Assess Health Care; 1995; 11(3):410-6. PubMed ID: 7591543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' use and perception of medication information leaflets.
    Nathan JP; Zerilli T; Cicero LA; Rosenberg JM
    Ann Pharmacother; 2007 May; 41(5):777-82. PubMed ID: 17405820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisapride and patient information leaflets.
    Sukkari SR; Sasich LD
    CMAJ; 2001 May; 164(9):1276-8; author reply 1278-9. PubMed ID: 11341134
    [No Abstract]   [Full Text] [Related]  

  • 13. A survey of the quality of information leaflets on hayfever available from general practices and community pharmacies.
    White P; Smith H; Webley F; Frew A
    Clin Exp Allergy; 2004 Sep; 34(9):1438-43. PubMed ID: 15347378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of instructions in patient information leaflets for the use of intranasal corticosteroid sprays: an observational study.
    Rollema C; van Roon EM; Schilder AG; de Vries TW
    BMJ Open; 2019 Jan; 9(1):e026710. PubMed ID: 30647049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient information: community pharmacy needs and perspectives.
    Juergens JP; Basara LR
    Top Hosp Pharm Manage; 1994 Oct; 14(3):47-57. PubMed ID: 10138928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient information leaflets on over-the-counter (OTC) medicines: the manufacturer's perspective.
    Bradley B; McCusker E; Scott E; Li Wan Po A
    J Clin Pharm Ther; 1995 Feb; 20(1):37-40. PubMed ID: 7775612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Typeface legibility of patient information leaflets intended for community-dwelling seniors.
    Chubaty A; Sadowski CA; Carrie AG
    Age Ageing; 2009 Jul; 38(4):441-7. PubMed ID: 19483246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Patient education responsibility, specialty and administration information from the viewpoint of the pharmaceutical industry].
    Granitza A
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):649-53. PubMed ID: 9527462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using alternative methodologies for evaluating patient medication leaflets.
    Krass I; Svarstad BL; Bultman D
    Patient Educ Couns; 2002 May; 47(1):29-35. PubMed ID: 12023098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Literacy demands of product information intended to supplement television direct-to-consumer prescription drug advertisements.
    Kaphingst KA; Rudd RE; DeJong W; Daltroy LH
    Patient Educ Couns; 2004 Nov; 55(2):293-300. PubMed ID: 15530767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.